Bonk, Inc. (NASDAQ:BNKK – Get Free Report)’s share price dropped 8.1% during trading on Tuesday . The company traded as low as $2.34 and last traded at $2.38. Approximately 26,399 shares were traded during mid-day trading, a decline of 59% from the average daily volume of 63,902 shares. The stock had previously closed at $2.59.
Analyst Ratings Changes
A number of brokerages have recently weighed in on BNKK. Weiss Ratings restated a “sell (d-)” rating on shares of Bonk in a research note on Monday, December 29th. Wall Street Zen upgraded shares of Bonk to a “sell” rating in a research report on Saturday, December 13th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Bonk has an average rating of “Sell”.
Read Our Latest Research Report on BNKK
Bonk Trading Down 8.1%
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the company. State Street Corp bought a new stake in shares of Bonk during the fourth quarter worth $33,000. Steward Partners Investment Advisory LLC bought a new stake in Bonk in the fourth quarter valued at approximately $37,000. Jane Street Group LLC acquired a new stake in Bonk during the 4th quarter worth $96,000. Finally, Geode Capital Management LLC acquired a new position in Bonk in the fourth quarter valued at about $128,000. 12.55% of the stock is currently owned by institutional investors.
About Bonk
Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.
Featured Articles
Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.
